Free Trial
NYSE:GRDN

Guardian Pharmacy Services (GRDN) Stock Price, News & Analysis

Guardian Pharmacy Services logo
$20.29 -0.41 (-2.00%)
Closing price 03:59 PM Eastern
Extended Trading
$20.28 0.00 (0.00%)
As of 04:04 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

About Guardian Pharmacy Services Stock (NYSE:GRDN)

Key Stats

Today's Range
$20.23
$20.71
50-Day Range
$19.65
$26.44
52-Week Range
$14.16
$26.91
Volume
89,560 shs
Average Volume
226,166 shs
Market Capitalization
$1.28 billion
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$25.67
Consensus Rating
Buy

Company Overview

Guardian Pharmacy Services Stock Analysis - MarketRank™

See Top-Rated MarketRank™ Stocks
44th Percentile Overall Score

GRDN MarketRank™: 

Guardian Pharmacy Services scored higher than 44% of companies evaluated by MarketBeat, and ranked 800th out of 922 stocks in the medical sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

  • Consensus Rating

    Guardian Pharmacy Services has received a consensus rating of Buy. The company's average rating score is 3.00, and is based on 3 buy ratings, no hold ratings, and no sell ratings.

  • Amount of Analyst Coverage

    Guardian Pharmacy Services has only been the subject of 2 research reports in the past 90 days.

  • Read more about Guardian Pharmacy Services' stock forecast and price target.
  • Earnings Growth

    Earnings for Guardian Pharmacy Services are expected to decrease by -3.45% in the coming year, from $0.87 to $0.84 per share.

  • Price to Book Value per Share Ratio

    Guardian Pharmacy Services has a P/B Ratio of 8.56. P/B Ratios above 3 indicate that a company could be overvalued with respect to its assets and liabilities.

  • Read more about Guardian Pharmacy Services' valuation and earnings.
  • Short Interest

    There is no current short interest data available for GRDN.
  • Dividend Yield

    Guardian Pharmacy Services does not currently pay a dividend.

  • Dividend Growth

    Guardian Pharmacy Services does not have a long track record of dividend growth.

  • Short Interest

    There is no current short interest data available for GRDN.
  • News Sentiment

    Guardian Pharmacy Services has a news sentiment score of 0.89. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a higher news sentiment than the 0.63 average news sentiment score of Medical companies.
  • News Coverage This Week

    MarketBeat has tracked 3 news articles for Guardian Pharmacy Services this week, compared to 3 articles on an average week.
  • MarketBeat Follows

    Only 1 people have added Guardian Pharmacy Services to their MarketBeat watchlist in the last 30 days. This is a decrease of 0% compared to the previous 30 days.
  • Insider Buying vs. Insider Selling

    In the past three months, Guardian Pharmacy Services insiders have sold more of their company's stock than they have bought. Specifically, they have bought $0.00 in company stock and sold $228,713,426.00 in company stock.

  • Percentage Held by Insiders

    63.71% of the stock of Guardian Pharmacy Services is held by insiders. A high percentage of insider ownership can be a sign of company health.

  • Read more about Guardian Pharmacy Services' insider trading history.
Receive GRDN Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Guardian Pharmacy Services and its competitors with MarketBeat's FREE daily newsletter.

GRDN Stock News Headlines

HIDDEN IN THE BOOK OF GENESIS…
“This land I will give to you…” — a 4,000-year-old line from Genesis may hold the key to unlocking a $150 trillion vault of untapped American wealth. Former CIA advisor Jim Rickards calls it the “Old Testament Wealth Code” — and says it could transform your financial future. He’s revealing everything in a new presentation.
Guardian Pharmacy Hosts Investor Day on June 18
GRDN Guardian Pharmacy Services, Inc.
See More Headlines

GRDN Stock Analysis - Frequently Asked Questions

Guardian Pharmacy Services' stock was trading at $20.26 at the beginning of the year. Since then, GRDN stock has increased by 0.1% and is now trading at $20.2860.

Guardian Pharmacy Services, Inc. (NYSE:GRDN) issued its earnings results on Monday, May, 12th. The company reported $0.21 earnings per share (EPS) for the quarter, missing the consensus estimate of $0.22 by $0.01. The firm had revenue of $329.31 million for the quarter, compared to analyst estimates of $321.21 million.
Read the conference call transcript
.

Guardian Pharmacy Services (GRDN) raised $102 million in an initial public offering on Thursday, September 26th 2024. The company issued 6,800,000 shares at a price of $14.00-$16.00 per share. Raymond James, Stifel and Truist Securities served as the underwriters for the IPO.

Guardian Pharmacy Services' top institutional shareholders include KLP Kapitalforvaltning AS (0.01%). Insiders that own company stock include William E Bindley, Thomas J Salentine Jr, Fred Burke, David K Morris, Kendall Forbes, John Ackerman and Steven D Cosler.
View institutional ownership trends
.

Shares of GRDN stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Based on aggregate information from My MarketBeat watchlists, some other companies that Guardian Pharmacy Services investors own include UnitedHealth Group (UNH) and Meta Platforms (META).

Company Calendar

Last Earnings
5/12/2025
Today
7/24/2025
Next Earnings (Estimated)
8/11/2025
Fiscal Year End
12/31/2025

Industry, Sector and Symbol

Stock Exchange
NYSE
Sector
Medical
Industry
MED - DRUGS
Sub-Industry
Retail
Current Symbol
NYSE:GRDN
Previous Symbol
NYSE:GRDN
CIK
1802255
Fax
N/A
Employees
3,400
Year Founded
N/A

Price Target and Rating

High Price Target
$28.00
Low Price Target
$21.00
Potential Upside/Downside
+26.5%
Consensus Rating
Buy
Rating Score (0-4)
3.00
Research Coverage
3 Analysts

Profitability

EPS (Trailing Twelve Months)
N/A
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
N/A
Net Margins
N/A
Pretax Margin
N/A
Return on Equity
N/A
Return on Assets
N/A

Debt

Debt-to-Equity Ratio
N/A
Current Ratio
1.14
Quick Ratio
0.84

Sales & Book Value

Annual Sales
$1.23 billion
Price / Sales
1.05
Cash Flow
$0.25 per share
Price / Cash Flow
81.50
Book Value
$2.37 per share
Price / Book
8.56

Miscellaneous

Outstanding Shares
63,290,000
Free Float
22,967,000
Market Cap
$1.28 billion
Optionable
N/A
Beta
N/A
The Next 7 Blockbuster Stocks for Growth Investors Cover

Wondering what the next stocks will be that hit it big, with solid fundamentals? Enter your email address to see which stocks MarketBeat analysts could become the next blockbuster growth stocks.

Get This Free Report

This page (NYSE:GRDN) was last updated on 7/24/2025 by MarketBeat.com Staff
From Our Partners